Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma

• Pierre Boyé ,

  Contributed equally to this work with: Pierre Boyé, François Serres, Laurent Marescaux, Dominique Tierny

  * E-mail: pierre_boye@hotmail.fr

  Affiliations Oncovet-Clinical-Research (OCR), SIRIC ONCOLille, Parc Eurasanté, Loos, France, Oncovet, SIRIC ONCOLille, Villeneuve d’Ascq, France

  http://orcid.org/0000-0003-2954-2842

  ⨯
• François Serres ,

  Contributed equally to this work with: Pierre Boyé, François Serres, Laurent Marescaux, Dominique Tierny

  Affiliations Oncovet-Clinical-Research (OCR), SIRIC ONCOLille, Parc Eurasanté, Loos, France, Oncovet, SIRIC ONCOLille, Villeneuve d’Ascq, France

  ⨯
• Laurent Marescaux ,

  Contributed equally to this work with: Pierre Boyé, François Serres, Laurent Marescaux, Dominique Tierny

  Affiliation Oncovet, SIRIC ONCOLille, Villeneuve d’Ascq, France

  ⨯
• Juliette Hordeaux,

  Affiliation Oncovet-Clinical-Research (OCR), SIRIC ONCOLille, Parc Eurasanté, Loos, France

  ⨯
• Emmanuel Bouchaert,

  Affiliation Oncovet-Clinical-Research (OCR), SIRIC ONCOLille, Parc Eurasanté, Loos, France

  ⨯
• Bruno Gomes,

  Current address: iTeos Therapeutics, Gosselies, Belgium

  Affiliation Institut de Recherche Pierre Fabre, Toulouse, France

  ⨯
• Dominique Tierny

  Contributed equally to this work with: Pierre Boyé, François Serres, Laurent Marescaux, Dominique Tierny

  Affiliations Oncovet-Clinical-Research (OCR), SIRIC ONCOLille, Parc Eurasanté, Loos, France, Oncovet, SIRIC ONCOLille, Villeneuve d’Ascq, France

  ⨯